Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
14
CURI Quote, Financials, Valuation and Earnings
Last price:
$3.92
Seasonality move
:
6.94%
Day range:
$3.84 - $4.00
52-week range:
$1.48 - $7.15
Dividend yield:
7.16%
P/E ratio:
--
P/S ratio:
3.36x
P/B ratio:
4.83x
Volume:
258K
Avg. volume:
953.3K
1-year change:
155.56%
Market cap:
$227.9M
Revenue:
$51.1M
EPS (TTM):
-$0.10
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Revenue Growth (YoY) | 119.8% | 79.86% | 9.52% | -27.11% | -10.12% | |
| Cost of Revenues | $15.4M | $36.9M | $51.8M | $35.6M | $25.4M | |
| Gross Profit | $24.2M | $34.3M | $26.2M | $21.3M | $25.8M | |
| Gross Profit Margin | 61.09% | 48.15% | 33.58% | 37.51% | 50.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63M | $87.1M | $78.2M | $46.8M | $39.1M | |
| Other Inc / (Exp) | -$10.1M | $14.7M | $955K | -$24.2M | -$2.6M | |
| Operating Expenses | $63M | $86.8M | $77.9M | $46.8M | $38.9M | |
| Operating Income | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$48.4M | -$37.3M | -$50.6M | -$48.4M | -$12.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $179K | $360K | $367K | $506K | $132K | |
| Net Income to Company | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Basic EPS (Cont. Ops) | -$3.30 | -$0.73 | -$0.96 | -$0.92 | -$0.24 | |
| Diluted EPS (Cont. Ops) | -$3.30 | -$1.02 | -$0.96 | -$0.92 | -$0.24 | |
| Weighted Average Basic Share | $18.9M | $51.5M | $52.8M | $53M | $54.5M | |
| Weighted Average Diluted Share | $18.9M | $51.8M | $52.8M | $53M | $54.5M | |
| EBITDA | -$28.7M | -$24M | -$11.7M | -$2.1M | $6.3M | |
| EBIT | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.1M | |
| Revenue (Reported) | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Operating Income (Reported) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.1M | |
| Operating Income (Adjusted) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.7M | $23.6M | $15.6M | $12.6M | $18.4M | |
| Revenue Growth (YoY) | 113.92% | 26% | -33.68% | -19.36% | 45.66% | |
| Cost of Revenues | $9.6M | $13.6M | $8.5M | $5.8M | $7.6M | |
| Gross Profit | $9.2M | $10M | $7.1M | $6.8M | $10.8M | |
| Gross Profit Margin | 48.93% | 42.44% | 45.66% | 53.67% | 58.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.4M | $14.4M | $12.1M | $10M | $15.3M | |
| Other Inc / (Exp) | $8.5M | $420K | -$21.5M | -$303K | -- | |
| Operating Expenses | $17.4M | $14.4M | $12.1M | $10M | $15.3M | |
| Operating Income | -$8.2M | -$4.4M | -$4.9M | -$3.3M | -$4.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $879K | -$4.4M | -$26.4M | -$3M | -$4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $49K | $64K | $133K | $45K | -$207K | |
| Net Income to Company | $830K | -$4.5M | -$26.6M | -$3.1M | -$3.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $830K | -$4.5M | -$26.6M | -$3.1M | -$3.7M | |
| Basic EPS (Cont. Ops) | $0.02 | -$0.09 | -$0.50 | -$0.06 | -$0.06 | |
| Diluted EPS (Cont. Ops) | -$0.14 | -$0.09 | -$0.50 | -$0.06 | -$0.06 | |
| Weighted Average Basic Share | $52.6M | $52.8M | $53M | $54.9M | $57.9M | |
| Weighted Average Diluted Share | $52.7M | $52.8M | $53M | $54.9M | $57.9M | |
| EBITDA | -$600K | $6.1M | $581K | $1.4M | -$869K | |
| EBIT | -$8.2M | -$4.4M | -$4.9M | -$3.3M | -$4.5M | |
| Revenue (Reported) | $18.7M | $23.6M | $15.6M | $12.6M | $18.4M | |
| Operating Income (Reported) | -$8.2M | -$4.4M | -$4.9M | -$3.3M | -$4.5M | |
| Operating Income (Adjusted) | -$8.2M | -$4.4M | -$4.9M | -$3.3M | -$4.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $55.3M | $90.8M | $56.6M | $51.8M | $66.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $24.1M | $55.6M | $40.6M | $26.7M | $30.3M | |
| Gross Profit | $31.2M | $35.2M | $16.1M | $25.1M | $36.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $81.3M | $89.5M | $52.1M | $39.3M | $44.1M | |
| Other Inc / (Exp) | $6.5M | $8.9M | -$23.6M | -$2.5M | -- | |
| Operating Expenses | $81.3M | $89.5M | $52.1M | $39.3M | $44.1M | |
| Operating Income | -$50.1M | -$54.3M | -$36.1M | -$14.2M | -$7.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$51.8M | -$47.4M | -$58.1M | -$14.6M | -$5.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $189K | $397K | $681K | $161K | -$296K | |
| Net Income to Company | -$52M | -$47.8M | -$58.8M | -$14.8M | -$5.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$52M | -$47.8M | -$58.8M | -$14.8M | -$5.5M | |
| Basic EPS (Cont. Ops) | -$1.04 | -$0.91 | -$1.11 | -$0.28 | -$0.10 | |
| Diluted EPS (Cont. Ops) | -$2.09 | -$0.91 | -$1.11 | -$0.28 | -$0.10 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$32M | -$10.3M | -$8.1M | $5.9M | $7.8M | |
| EBIT | -$50.1M | -$54.3M | -$36.1M | -$14.2M | -$7.8M | |
| Revenue (Reported) | $55.3M | $90.8M | $56.6M | $51.8M | $66.6M | |
| Operating Income (Reported) | -$50.1M | -$54.3M | -$36.1M | -$14.2M | -$7.8M | |
| Operating Income (Adjusted) | -$50.1M | -$54.3M | -$36.1M | -$14.2M | -$7.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $44M | $63.5M | $42.1M | $37M | $52.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $19.4M | $38.4M | $27.4M | $18.6M | $23.5M | |
| Gross Profit | $24.6M | $25.1M | $14.7M | $18.4M | $28.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $59M | $61.5M | $35.4M | $27.9M | $32.9M | |
| Other Inc / (Exp) | $6.5M | $683K | -$23.9M | -$2.2M | -$393K | |
| Operating Expenses | $59M | $61.5M | $35.4M | $27.9M | $32.9M | |
| Operating Income | -$34.5M | -$36.3M | -$20.7M | -$9.5M | -$3.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$26.1M | -$36.2M | -$43.8M | -$10M | -$2.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $128K | $165K | $479K | $134K | -$294K | |
| Net Income to Company | -$26.2M | -$36.4M | -$44.2M | -$10.1M | -$2.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$26.2M | -$36.4M | -$44.2M | -$10.1M | -$2.6M | |
| Basic EPS (Cont. Ops) | -$0.53 | -$0.69 | -$0.83 | -$0.19 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.72 | -$0.69 | -$0.83 | -$0.19 | -$0.05 | |
| Weighted Average Basic Share | $153.2M | $158.3M | $159M | $161.8M | $172.6M | |
| Weighted Average Diluted Share | $153.7M | $158.3M | $159M | $161.8M | $172.6M | |
| EBITDA | -$19.6M | -$6.2M | -$2.7M | $5.3M | $7M | |
| EBIT | -$34.5M | -$36.3M | -$20.7M | -$9.5M | -$3.9M | |
| Revenue (Reported) | $44M | $63.5M | $42.1M | $37M | $52.5M | |
| Operating Income (Reported) | -$34.5M | -$36.3M | -$20.7M | -$9.5M | -$3.9M | |
| Operating Income (Adjusted) | -$34.5M | -$36.3M | -$20.7M | -$9.5M | -$3.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.2M | $83.4M | $55.5M | $38.2M | $32.2M | |
| Short Term Investments | $22.2M | $65.8M | $15M | -- | $24.2M | |
| Accounts Receivable, Net | $7.2M | $23.5M | $10.9M | $4.8M | $6.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.5M | $6.4M | $3.1M | $2.3M | $1.2M | |
| Total Current Assets | $51.2M | $113.3M | $69.5M | $45.3M | $39.5M | |
| Property Plant And Equipment | $1.3M | $1.3M | $4.8M | $4.1M | $3.6M | |
| Long-Term Investments | $2.8M | $25.5M | $10.8M | $6.4M | $11.3M | |
| Goodwill | -- | $2.8M | -- | -- | -- | |
| Other Intangibles | $32.9M | $74.2M | $68.5M | $44.9M | $31.5M | |
| Other Long-Term Assets | $254K | $689K | $539K | $358K | $257K | |
| Total Assets | $88.6M | $217.6M | $154.1M | $101M | $86.9M | |
| Accounts Payable | $3.6M | $3.4M | $6.1M | $4.8M | $5.6M | |
| Accrued Expenses | $3.3M | $12.4M | $7.8M | $1.3M | $2.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $365K | $396K | |
| Other Current Liabilities | $2.1M | $9.7M | $2.9M | $1.4M | $2M | |
| Total Current Liabilities | $21.7M | $48M | $31M | $23.4M | $23.9M | |
| Long-Term Debt | -- | -- | $4.6M | $4.3M | $3.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.6M | $55.6M | $36.5M | $28.4M | $29.1M | |
| Common Stock | $4K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | $10K | -$222K | -$40K | -- | -- | |
| Common Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Liabilities and Equity | $88.6M | $217.6M | $154.1M | $101M | $86.9M | |
| Cash and Short Terms | $33.4M | $83.4M | $55.5M | $38.2M | $32.2M | |
| Total Debt | -- | -- | $4.6M | $4.3M | $3.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $83.2M | $64.3M | $40.8M | $33.3M | $27.8M | |
| Short Term Investments | $59.5M | $16.9M | -- | $23.6M | -- | |
| Accounts Receivable, Net | $13.3M | $17.2M | $6.9M | $4.5M | $9.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.6M | $1.6M | $1.4M | $1.3M | -- | |
| Total Current Assets | $100.1M | $83M | $49.1M | $39.1M | $38M | |
| Property Plant And Equipment | $1.3M | $5M | $4.2M | $3.6M | $3.3M | |
| Long-Term Investments | $58.6M | $11M | $6.7M | $10.7M | $5.1M | |
| Goodwill | $3M | -- | -- | -- | -- | |
| Other Intangibles | $63.2M | $75.2M | $45.9M | $33.9M | -- | |
| Other Long-Term Assets | $698K | $546K | $411K | $267K | -- | |
| Total Assets | $226.9M | $174.7M | $106.3M | $87.6M | $74.7M | |
| Accounts Payable | $5.5M | $7.6M | $7M | $3.8M | $2.9M | |
| Accrued Expenses | $4.8M | $7.5M | $4.2M | $1.4M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $7.5M | $5M | $128K | $1.6M | -- | |
| Total Current Liabilities | $39.9M | $37.8M | $24.2M | $20.6M | $23.5M | |
| Long-Term Debt | -- | $4.7M | $4.4M | $4M | $3.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $55.9M | $44.2M | $29.4M | $25.4M | $27.5M | |
| Common Stock | $5K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | -$1.4M | -$182K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $171M | $130.5M | $76.9M | $62.2M | $47.2M | |
| Total Liabilities and Equity | $226.9M | $174.7M | $106.3M | $87.6M | $74.7M | |
| Cash and Short Terms | $83.2M | $64.3M | $40.8M | $33.3M | $27.8M | |
| Total Debt | -- | $4.7M | $4.4M | $4M | $3.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Depreciation & Amoritzation | $10.1M | $28.5M | $40M | $23.4M | $19.5M | |
| Stock-Based Compensation | $4.3M | $7M | $6.6M | $4M | $6.6M | |
| Change in Accounts Receivable | -$5.4M | -$16.2M | $11.9M | $6.1M | -$1.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$53.5M | -$73.2M | -$39.5M | -$16.2M | $8.2M | |
| Capital Expenditures | $367K | $351K | $130K | $5K | -- | |
| Cash Acquisitions | -- | $5.4M | -- | -- | -- | |
| Cash From Investing | $25.5M | -$74.9M | $62.7M | $14M | -$31.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | $4.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $9.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $251K | |
| Other Financing Activities | $36.4M | -$1.2M | -$218K | -$123K | -$2.7M | |
| Cash From Financing | $36.6M | $148.3M | -$218K | -$123K | -$7M | |
| Beginning Cash (CF) | $8.8M | $17.5M | $40.5M | $38.2M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.6M | $163K | $23M | -$2.3M | -$30.3M | |
| Ending Cash (CF) | $17.4M | $17.7M | $63.5M | $35.9M | -$22.3M | |
| Levered Free Cash Flow | -$53.9M | -$73.6M | -$39.7M | -$16.2M | $8.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $830K | -$4.5M | -$26.6M | -$3.1M | -$3.7M | |
| Depreciation & Amoritzation | $7.6M | $10.5M | $5.5M | $4.6M | $3.6M | |
| Stock-Based Compensation | $1.6M | $1.7M | $897K | $2.7M | $7M | |
| Change in Accounts Receivable | -$2.5M | -$5.6M | $2.2M | $106K | $2.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$18.4M | -$12.6M | -$3M | $2.3M | $4.4M | |
| Capital Expenditures | $116K | $10K | -- | -- | -- | |
| Cash Acquisitions | $1.4M | -- | -- | -- | -- | |
| Cash From Investing | $28.3M | $36.7M | -$992K | -$30M | $8.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $1.3M | $4.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $192K | -- | |
| Other Financing Activities | -$67K | -$17K | -$19K | -$688K | -- | |
| Cash From Financing | $21K | -$17K | -$19K | -$2.2M | -$5.8M | |
| Beginning Cash (CF) | $23.7M | $47.3M | $40.8M | $9.7M | $14.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.9M | $24.1M | -$4M | -$29.9M | $7.2M | |
| Ending Cash (CF) | $33.6M | $71.4M | $36.8M | -$20.2M | $21.3M | |
| Levered Free Cash Flow | -$18.6M | -$12.6M | -$3M | $2.3M | $4.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$52M | -$47.8M | -$58.8M | -$14.8M | -$5.5M | |
| Depreciation & Amoritzation | $18.1M | $43.4M | $28M | $20.1M | $15.5M | |
| Stock-Based Compensation | $8.5M | $6.6M | $5.2M | $5.1M | $11.9M | |
| Change in Accounts Receivable | -$7.5M | -$3.8M | $9.5M | $2.4M | -$4.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$59.8M | -$62.2M | -$22.4M | $2.6M | $12.1M | |
| Capital Expenditures | $359K | $190K | $5K | -- | $77K | |
| Cash Acquisitions | $5.4M | -- | -- | -- | -- | |
| Cash From Investing | -$110.9M | $86.4M | $16M | -$30M | $15.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $2.7M | $18.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $218K | $33K | |
| Other Financing Activities | $37.2M | -$543K | -$116K | -$803K | -- | |
| Cash From Financing | $186M | -$538K | -$116K | -$3.7M | -$23.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $15.3M | $23.6M | -$6.5M | -$31.1M | $4.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$60.2M | -$62.4M | -$22.4M | $2.6M | $12M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$26.2M | -$36.4M | -$44.2M | -$10.1M | -$2.6M | |
| Depreciation & Amoritzation | $14.8M | $30.1M | $18.1M | $14.8M | $10.8M | |
| Stock-Based Compensation | $5.4M | $5.1M | $3.6M | $4.7M | $10.1M | |
| Change in Accounts Receivable | -$6M | $6.3M | $4M | $260K | -$3.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$41.8M | -$30.7M | -$13.6M | $5.1M | $9.1M | |
| Capital Expenditures | $291K | $130K | $5K | -- | $77K | |
| Cash Acquisitions | -$2.6M | -- | -- | -- | -- | |
| Cash From Investing | -$100.6M | $60.7M | $14M | -$30M | $16.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $2.7M | $17.3M | |
| Special Dividend Paid | -- | -- | -- | -- | $100K | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $218K | -- | |
| Other Financing Activities | -$796K | -$178K | -$76K | -$756K | -$1.3M | |
| Cash From Financing | $148.7M | -$178K | -$76K | -$3.7M | -$19.8M | |
| Beginning Cash (CF) | $59.1M | $95.5M | $134.8M | $88.2M | $30.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.3M | $29.8M | $297K | -$28.5M | $6.2M | |
| Ending Cash (CF) | $65.4M | $125.3M | $135.1M | $59.7M | $36.7M | |
| Levered Free Cash Flow | -$42.1M | -$30.9M | -$13.6M | $5.1M | $9M | |
Related Companies
Get CURI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CURI
Sector
P/E ratio
--
16.33x
PEG ratio
-1.52x
0.00x
P/B ratio
4.83x
1.30x
Price / LTM sales
3.36x
0.86x
Growth Metrics
CURI
Sector
Revenue growth
45.66%
1.07%
Earnings growth
-15.77%
9.35%
Revenue (5-year growth)
23.19%
1.1%
Earnings forecast
-$0.02
$0.05
Profitability
CURI
Sector
Profitability FY 2024
$25.8M
$109.7M
Return on invested capital
-9.21%
0.48%
Return on assets
-6.6%
-0.17%
Return on equity
-9.91%
1.42%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
10
Estimated Next Earnings Date
Feb
11
Balance Sheet
CURI
Sector
Total cash
$27.8M
$72.3M
Short term investments
$24.2M
$24.7M
Total assets
$86.9M
$549.2M
Long term debt
$3.6M
$11.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
